Cohance Lifesciences' promoters, Jusmiral Holdings and Berhyanda Limited, have released encumbrances on over 57% of the company's shares. This follows the repayment of loans under a previous agreement, with a new USD 285 million facility now in place.
Cohance Lifesciences Promoters Release Significant Share Encumbrance Following Debt Refinancing
Jusmiral Holdings Limited and Berhyanda Limited have released encumbrances on a total of 219,930,170 shares of Cohance Lifesciences Ltd, representing 57.49% of the company's total share capital. The release, effective June 16, 2026, is a result of the full repayment of loans previously availed under a Notes Purchase Agreement. ## What just happened Promoter entities Jusmiral Holdings Limited and Berhyanda Limited have successfully cleared their existing loan obligations, leading to the unpledging of a substantial portion of their holdings in Cohance Lifesciences. Jusmiral Holdings released 92,390,578 shares (24.15% of total capital), and Berhyanda Limited released 127,539,592 shares (33.34% of total capital). ## Why this matters This move signifies the deleveraging at the promoter level and a restructuring of their financing arrangements. The release of these shares can be viewed positively by the market as it indicates improved financial health for the promoters and potentially reduces overhang on the stock. ## The backstory The encumbrance was placed on these shares as security for loans taken under a Notes Purchase Agreement. The repayment of these loans has now led to the release of that security. ## What changes now While the previous loan facility is closed, the company has simultaneously executed a new facility agreement on June 11, 2026. This new agreement involves term loan facilities aggregating to USD 285 million. A new encumbrance process is being initiated for this latest facility, in compliance with Takeover Regulations. ## Risks to watch Investors should monitor the details of the new USD 285 million facility and the subsequent encumbrance process. While debt restructuring is common, the terms and impact of the new financing on the promoter group's financial flexibility remain key. ## Peer comparison Information on specific peer promoter financing activities is not directly comparable without detailed analysis of their capital structures and loan agreements. ## Context metrics (time-bound) * **Shares Released:** 219,930,170 (57.49% of total share capital) * **Release Date:** June 16, 2026 * **New Facility Agreement Date:** June 11, 2026 * **New Facility Amount:** USD 285 million ## What to track next Investors should closely follow any further disclosures regarding the specifics of the new USD 285 million facility and the timeline for the initiation of the new encumbrance process.
